Taylor Adam J, Kay Robert D, Tye Erik Y, Bryman Jason A, Longjohn Donald, Najibi Soheil, Runner Robert P
Harbor-UCLA Medical Center, Torrance, California, USA.
Rancho Los Amigos National Rehabilitation Center, Downey, California, USA.
Bone Jt Open. 2021 Oct;2(10):871-878. doi: 10.1302/2633-1462.210.BJO-2021-0072.R1.
This study aimed to evaluate whether an enhanced recovery protocol (ERP) for arthroplasty established during the COVID-19 pandemic at a safety net hospital can be associated with a decrease in hospital length of stay (LOS) and an increase in same-day discharges (SDDs) without increasing acute adverse events.
A retrospective review of 124 consecutive primary arthroplasty procedures performed after resuming elective procedures on 11 May 2020 were compared to the previous 124 consecutive patients treated prior to 17 March 2020, at a single urban safety net hospital. Revision arthroplasty and patients with < 90-day follow-up were excluded. The primary outcome measures were hospital LOS and the number of SDDs. Secondary outcome measures included 90-day complications, 90-day readmissions, and 30day emergency department (ED) visits.
The mean LOS was significantly reduced from 2.02 days (SD 0.80) in the pre-COVID cohort to 1.03 days (SD 0.65) in the post-COVID cohort (p < 0.001). No patients in the pre-COVID group were discharged on the day of surgery compared to 60 patients (48.4%) in the post-COVID group (p < 0.001). There were no significant differences in 90-day complications (13.7% (n = 17) vs 9.7% (n = 12); p = 0.429), 30-day ED visits (1.6% (n = 2) vs 3.2% (n = 4); p = 0.683), or 90-day readmissions (2.4% (n = 3) vs 1.6% (n = 2); p = 1.000) between the pre-COVID and post-COVID groups, respectively.
Through use of an ERP, arthroplasty procedures were successfully resumed at a safety net hospital with a shorter LOS and increased SDDs without a difference in acute adverse events. The resulting increase in healthcare value therefore may be considered a 'silver lining' to the moratorium on elective arthroplasty during the COVID-19 pandemic. These improved efficiencies are expected to continue in post-pandemic era. Cite this article: 2021;2(10):871-878.
本研究旨在评估在一家安全网医院于新冠疫情期间制定的关节置换术强化康复方案(ERP)是否可使住院时间(LOS)缩短、当日出院(SDD)人数增加,且不增加急性不良事件。
对2020年5月11日恢复择期手术后连续进行的124例初次关节置换手术进行回顾性分析,并与2020年3月17日前在同一家城市安全网医院连续治疗的124例患者进行比较。翻修关节置换术及随访时间不足90天的患者被排除。主要观察指标为住院LOS和SDD人数。次要观察指标包括90天并发症、90天再入院率及30天急诊科就诊次数。
新冠疫情前队列的平均LOS从2.02天(标准差0.80)显著降至新冠疫情后队列的1.03天(标准差0.65)(p<0.001)。新冠疫情前组无患者在手术当日出院,而新冠疫情后组有60例(48.4%)患者在手术当日出院(p<0.001)。新冠疫情前组与后组在90天并发症(13.7%(n = 17)对9.7%(n = 12);p = 0.429)、30天急诊科就诊次数(1.6%(n = 2)对3.2%(n = 4);p = 0.683)或90天再入院率(2.4%(n = 3)对1.6%(n = 2);p = 1.000)方面均无显著差异。
通过使用ERP,一家安全网医院成功恢复了关节置换手术,住院LOS缩短,SDD人数增加,急性不良事件无差异。因此,由此带来的医疗价值提升可被视为新冠疫情期间择期关节置换术暂停的“一线希望”。预计这些提高的效率在疫情后时代仍将持续。引用本文:2021;2(10):871-878。